Express News | Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target
Express News | Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs...
Trump Vs Harris: Democratic Candidate Holds Narrow Lead Over Ex-president In Tightening Race, New Poll Shows
Top Gap Ups and Downs on Tuesday: SAP, BHP, RIO and More
Is Humana a Deep Value Stock to Buy?
Humana Raised to Outperform From Market Perform by Bernstein
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says
Humana Gets a Rare Stock Upgrade at Wall Street Amid Recent Woes
Humana Is Maintained at Outperform by RBC Capital
Humana Analyst Ratings
Spotlight on Humana: Analyzing the Surge in Options Activity
RBC Capital Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $265
RBC Cuts Price Target on Humana to $265 From $400, Keeps Outperform Rating
RBC Capital Reaffirms Their Buy Rating on Humana (HUM)
Cognizant's Revenue Outlook: A Hold Rating Amidst Humana's Anticipated Spending Changes
Bernstein Upgrades Humana(HUM.US) to Buy Rating, Cuts Target Price to $308
Humana Upgraded to Outperform From Market Perform at Bernstein
Humana Inc. (HUM): Among Seth Klarman's Top Stock Picks
Top Gap Ups and Downs on Monday: NVO, PFE, EQNR and More
10 Health Care Stocks Whale Activity In Today's Session